西安医学院深耕临床医学、免疫学、药理学学科建设，拥有雄厚医学师资与完备科研平台，依托校内优质医学教研资源，对标国内外肿瘤医学培养标准，为本硕士合作项目提供专项学业辅导、科研指导、临床研学全流程教学支撑，筑牢学生医学专业根基。
伦敦城市大学肿瘤免疫疗治疗硕士课程，系统讲授手术、放疗、化疗等传统癌症诊疗手段，联动药理学、免疫学资深科研人员，以及校内细胞与分子免疫学研究中心专家授课。项目鼓励学生加入行业专业学会精进专业能力，聚焦免疫联合药物靶向抗癌前沿研究，深耕肿瘤治愈前沿诊疗方向。
伦敦城市健康学院举办的肿瘤免疫治疗硕士专业依托外方肿瘤免疫学科顶尖教研实力，结合中方医学师资辅导优势，旨在培养掌握前沿肿瘤免疫诊疗技术、适配科研及临床岗位的国际化高端医学人才。该专业硕士实行2+0全程国内就读培养模式。由英方专任师资入校授课，承担三分之一教学内容，学生毕业后可获得英国伦敦城市大学硕士学位证书。学院颁发的英方学士学位证书与英国本土颁发的学位证书效力完全等同，全球认可通用，且均可通过中国教育部留学服务中心认证。
The Cancer Immunotherapy 2+0 Master's Programme at the London Met Health Institute, Xi'an Medical University draws on the complementary strengths of both partner institutions to provide advanced education in one of the fastest-growing fields of biomedical science. Xi'an Medical University offers a strong academic foundation through its well-established disciplines of Clinical Medicine, Immunology, and Pharmacology, supported by distinguished faculty members and high-quality research platforms.
The programme provides comprehensive academic supervision and research training, enabling students to develop a solid grounding in cancer biology, immunology, and translational medicine.London Metropolitan University delivers a well-structured curriculum covering conventional cancer treatments, including surgery, radiotherapy, and chemotherapy, while placing a strong emphasis on emerging therapeutic approaches. Courses are taught by experts in pharmacology and immunology together with researchers from the Cell and Molecular Immunology Research Centre, with specialist expertise in targeted therapies, cellular immunotherapy, and cancer vaccine development.
By integrating the academic strengths and research resources of both institutions, the programme addresses the needs of China's rapidly expanding biopharmaceutical industry while aligning with global standards in oncology research and drug development. Graduates will be well prepared for careers in cancer research, pharmaceutical research and development, translational medicine, and international biomedical innovation, while benefiting from competitive pathways to doctoral study and employment with leading pharmaceutical and biotechnology companies in China and abroad.